EGFR mutation and resistance of non-small-cell lung cancer to gefitinib .Antitumor activity of alectinib(CH5424802 / RO5424802)for ALK-rearranged NSCLC with or without prior crizotinib treatment in bioequivalence study .Randomized phase Ⅱ trial of gemcita ......